Replies to post #676660 on NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

Why are these Academic Institutions licencing their research innovations to NWBO and not to deep pocketed Big Pharma? These reasearchers are advancing science as is NWBO. BP maximizes money and therefore could be incentivized to delay or bury innovations that threaten status quo money makers.

[beartrap12]

The in-licensing agreements with academia also shows that NWBO is continually thinking to the future, how to better our product and extend our patent coverage. It's interesting that management talks in the past tense about in-licensing patents, but doesn't tell us how many of these agreements were reached. However, they do indicate that the in-licensing involves what appears to me to be 3 different types of products perhaps a separate method for their use: certain vaccine compositions, immunogenic peptide antigens, and cell - based immunotherapy compositions and methods for their use.

I see nothing at all in this 10K that indicates management intends to sell the company anytime soon. I see lots of indications that they intend to develop NWBO into a thriving company with franchises that other companies will fight to pay us for, and a continuously expanding patent platform that will increase DCVax's cancer-fighting abilities.

And I predict they will be adding new blood to our aging staff within the next 18-24 months.